Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: Outcome of treatment with amino acids
- 211 Downloads
Congenital microcephaly, intractable seizures and severe psycho-motor retardation characterize 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, a disorder of L-serine biosynthesis. The enzyme defect results in low concentrations of serine and to a variable degree of glycine in plasma and cerebrospinal fluid. Short-term beneficial effects have been reported of oral treatment with the deficient amino acids. In this paper, we report the first follow-up data of amino acid therapy in five patients treated for 3–7.5 years. Different treatment regimes were used, but a favourable response to amino acids was observed in all patients. A major reduction in seizure frequency occurred in all patients; two patients became free of seizures. Amino acids were well tolerated and no adverse effects were documented. A progress of psychomotor development was only observed in one patient, diagnosed early and treated with a high dosage of L-serine. A favourable outcome of 3-PGDH deficiency depends on early diagnosis and treatment.
Unable to display preview. Download preview PDF.
- Brodehl J, Gellissen K, Hagge W (1968) Tubular re-resorption of free amino acids in infancy and childhood. Monatsschr Kinderheilkd 116: 305-308.Google Scholar
- de Koning TJ, Duran M, Dorland L, et al (1998) Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency. Ann Neurol 44: 261-265.Google Scholar
- de Koning TJ, Jaeken J, Pineda M, Van Maldergem L, Poll-The BT, van der Knaap MS (2000) Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics 31: 287-292.Google Scholar
- de Koning TJ, Poll-The BT, Jaeken J (1999) Continuing education in neurometabolic disorders—serine deficiency disorders. Neuropediatrics 30: 1-4.Google Scholar
- Hausler MG, Jaeken J, Monch E, Ramaekers VT (2001) Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings. Neuropediatrics 32: 191-195.Google Scholar
- Jaeken J, Detheux M, Van Maldergem L, Foulon M, Carchon H, Van Schaftingen E (1996) 3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis. Arch Dis Child 74: 542-545.Google Scholar
- Klomp LW, de Koning TJ, Malingre HE, et al (2000) Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency—a neurometabolic disorder associated with reduced l-serine biosynthesis. Am J Hum Genet 67: 1389-1399.Google Scholar
- Pineda M, Vilaseca MA, Artuch R, et al (2000) 3-Phosphoglycerate dehydrogenase deficiency in a patient with West syndrome. Dev Med Child Neurol 42: 629-633.Google Scholar
- Smith QR, Momma S, Aoyagi M, Rapoport SI (1987) Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49: 1651-1658.Google Scholar
- Snell K (1984) Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzyme Regul 22: 325-400.Google Scholar